Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Hiv · Cryptococcal Meningitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Infectious Diseases Institute, Kampala, Uganda
Contact: Study coordinator (David Meya, PhD) · david.meya@gmail.com
Mbarara University of Science and Technology, Mbarara, Uganda
Contact: Study coordinator (Conrad Muzoora) · conradmuzoora@gmail.com · 256772547175

Study leads

David R Boulware, MD, MPH
Principal Investigator
University of Minnesota
David B Meya, MBChB, MMed, PhD
Principal Investigator
Uganda

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals

HIV-1-infection · Non-Adherence, Medication

Abroad (travel likely)RecruitingPHASE3

Keelung, Taiwan · Taipei, Taiwan

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants

HIV

Abroad (travel likely)Recruiting

Bethesda, United States

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Atlanta, United States

Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS

Smoking Cessation · HIV

Abroad (travel likely)Recruiting

Phnom Penh, Cambodia · Phnom Penh, Cambodia